Bản đồ bố trí tại khu vực cổng A Công viên Sa Đéc, có chiều dài 45m, chiều rộng 25m, nổi bật với màu sắc sặc sỡ, được tạo hình công phu từ các giống hoa, kiểng nhưa cúc, hoa lan, hoa giấy, hoa hồng; ...
Members of the U.S. Naval Forces Southern Command/U.S. 4th Fleet reserve unit perform pushups for their physical fitness assessment on May 15, 2022. (MC2 Daniel Cleary/U.S. Navy) The U.S. Navy ...
U.S. Marines and Sailors conduct an early morning physical training session on the flight deck of the amphibious assault ship USS Bataan (LHD 5) during Fleet Week Miami, May 8, 2024. U.S. Navy Photo ...
A Butler Twp. man who repeatedly violated a Protection from Abuse (PFA) order was sentenced to jail Thursday following a hearing in the Luzerne County Court of Common Pleas. Thomas Fedorko, 44, was ...
Abbott’s VOLT-AF IDE trial enrolled 392 patients and was conducted across 40 centres in Australia, Canada, Europe, and the US. Credit: JarTee/Shutterstock.com. The US Food and Drug Administration (FDA ...
On Monday, the U.S. Food and Drug Administration (FDA) approved Abbott Laboratories’ (NYSE: ABT) Volt PFA System to treat patients battling atrial fibrillation (AFib). AFib is the most common type of ...
ABBOTT PARK, Ill. - Abbott (NYSE:ABT), the $218 billion healthcare equipment giant with revenue of $43.8 billion over the last twelve months, announced Monday that the U.S. Food and Drug ...
Abbott will soon enter the competitive U.S. pulsed field ablation (PFA) market, having just received FDA approval for its Volt PFA System to treat atrial fibrillation. The highly anticipated ...
Abbott's Volt™ PFA System, the latest generation of cardiac ablation technology, is designed for people battling heart rhythm disorders such as atrial fibrillation (AFib) Pulsed field ablation – or ...
The Volt PFA system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with AFib. Abbott said it plans ...
Despite the earlier movement by competitors in PFA, Abbott CEO Robert Ford told investors in October that the company is “right on time, and we’re complete with the full portfolio.” The company hopes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback